Olivier Elemento (@ElementoLab) header
Olivier Elemento (@ElementoLab) profile picture

Director, Englander Institute for Precision Medicine @WCMenglanderIPM, Associate Director @wcmc_ctsc & ICB, Co-Founder @volastratx & @onethreebiotech

New York city
Joined January 2012
Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)Photo by Olivier Elemento (@ElementoLab)
Olivier Elemento retweeted
Introducing Gemini 4 Neon! Pushing the frontier across domains and punching above its model class in a meaningful way. To me, Neon feels like the right balance of intelligence, speed, and usability. Available now across @GoogleAIStudio, the API, and more!
587
693
510
9,917
628,727
Olivier Elemento retweeted
Now add success for an acute myelogenous leukemia (AML) vaccine, a 41% reduction of death, extending survival for nearly a year, a Phase 2 randomized trial fiercebiotech.com/biotech/se…
The mRNA vaccine success vs melanoma in a Phase definitive 3 randomized trial today is on top of signs of success for personalized mRNA neoantigen vaccines vs pancreatic cancer, triple negative breast cancer, and non-small cell lung cancer wsj.com/health/pharma/modern…
7
39
242
18,169
Please join us tomorrow for Dr. @Chris_Barbieri1's @WCMEnglanderIPM's Research Conference talk “Presurgical Trials to Understand #ProstateCancer Biology and Therapeutic Responses.” Snap the QR code below to register!
Register today for our next @WCMEnglanderIPM #PrecisionMedicine talk on #ProstateCancer by our colleague Dr. Chris Barbieri (@Chris_Barbieri1) on November 19th at 1 pm!
2
4
267
Don't miss today's @WCMEnglanderIPM #AI Clinic, "Hardening Your Vibe Analyses with #Mycelium," led by Dr. Arjun Raj (@arjunrajlab) from @UofPenn's #BioEngineering #Genetics! Snap the QR code below to register!
Mark your calendar and plan to join us (virtually) on Nov. 18th at 2 pm for the @WCMEnglanderIPM #AI Clinic "Hardening Your Vibe Analyses with #Mycelium," led by Dr. Arjun Raj (@arjunrajlab) from @UofPenn #BioEngineering #Genetics! Snap the QR code below to register.
2
6
268
Replying to @urotoday
@urotoday just published, "Comparison of #WGS with clinical targeted panel sequencing of metastatic prostate cancer: insights from real-world data," by @WCMEnglanderIPM @ElementoLab @cnsternberg @JuanMiguel12148 @DrScottTagawa @DrDavidNanus, et al. urotoday.com/recent-abstract…
3
3
213
Don't miss the CUP abstract "Resolving tumor-of-origin from incomplete clinical data: a multimodal #AI framework integrating #histopathology, #transcriptomics & #genomics," presented as an oral platform at #ESMOAI26 by @WCMEnglanderIPM and @WCMCPathology w/@BostonGeneCorp
3
3
226
Olivier Elemento retweeted
Some of you have been asking very politely. Some of you have just been asking. GPT-6.2 Astra and Sol are now available. Super efficient and built to perform where it counts—the real world. openai.com/index/introducing…
2,216
3,584
3,658
35,473
9,672,942
🚨 A new cancer vaccine appears to significantly improve survival in people in remission from acute myeloid leukemia (AML), according to new results from a phase 3 clinical trial. The vaccine, galinpepimut-S (GPS), is an “off-the-shelf” vaccine invented by MSK leukemia specialist and physician-scientist Dr. David A. Scheinberg (@DASLab_MSKCC). In the trial of 126 patients, it reduced the risk of death by 41%. Median overall survival was 24.0 months with the vaccine compared with 14.7 months for patients on standard treatments. “These data bring us closer to having the first off-the-shelf vaccine for AML patients." Learn more: bit.ly/4fDoAmS
5
67
17
312
20,695
Olivier Elemento retweeted
The code of life is written in nucleic acids, but proteins carry out the instructions. New work from @MSKCancerCenter led by the brilliant @LauraCKida introduces sctRNA-seq, a new single-cell assay that defines how cells translate between these languages biorxiv.org/content/10.64898…
5
40
177
9,077
Join us Wednesday for the @WCMEnglanderIPM #AI Clinic, "Hardening Your Vibe Analyses with #Mycelium," led by Dr. Arjun Raj (@arjunrajlab) from @UofPenn #BioEngineering #Genetics! Snap the QR code below to register!
Mark your calendar and plan to join us (virtually) on Nov. 18th at 2 pm for the @WCMEnglanderIPM #AI Clinic "Hardening Your Vibe Analyses with #Mycelium," led by Dr. Arjun Raj (@arjunrajlab) from @UofPenn #BioEngineering #Genetics! Snap the QR code below to register.
1
2
6
353
Researchers at MSK have developed a new computational approach to better understand why #Tcells, the immune system’s primary cancer-fighting cells, respond differently to immunotherapies. Led by computational oncologists @bengrbm and @SohrabShah, the team created a statistical model called TCRi that links a T cell’s unique receptor sequence to its biological behavior, helping reveal how these cells recognize and react to cancer. By analyzing more than 167,000 T cells from patients treated with checkpoint inhibitor immunotherapies, the researchers aimed to uncover how a T cell’s genetic identity influences its activity and how those behaviors change during treatment, potentially improving the ability to predict which patients will benefit from immunotherapy. “This approach produces a standardized measurement that lets us compare results across different studies and clinical trials,” Dr. Greenbaum says. “We have a way to learn from this data what a meaningful T cell response to an immunotherapy looks like — or doesn’t.” Learn more about this research: bit.ly/48yVscR
17
1
55
3,671
Olivier Elemento retweeted
Hugely important paper. First came myeloma: we learned that we can detect precursor lesions years in advance. Now AML, the classic "out of the blue" blood cancer, turns out to have pre-malignant clones detectable years in advance. We'll keep working on cures, but it's time to start thinking about screening and prevention strategies for blood cancers.
How does leukaemia develop? 🩸 How long does it take? ⏳ 🌟 Our paper, started back when I was a PhD student in @jrblundell’s lab, is out today in @Nature 🌟 Yearly blood samples from women who developed AML in later life let us trace it back decades 👇 doi.org/10.1038/s41586-026-1…
1
2
29
1,642
Olivier Elemento retweeted
I joined @TheEconomist podcast to discuss how agentic AI is transforming the way we do science.
5
13
80
6,469
Behold: The full JUMP Cell Painting chemical dataset preprint! Images + 1.53 billion single-cell profiles for 115,796 compounds in human cells, made across 12 labs. All freely available 🧵 biorxiv.org/content/10.1101/…
13
59
5
245
14,048
Olivier Elemento retweeted
How do cancers emerge from healthy tissue? In @Nature today: leukaemia evolving in yearly blood samples up to 15 yrs before AML. First driver by age 20; each new driver multiplies growth 2–3×. A remarkably simple set of mathematical rules recapitulate it. nature.com/articles/s41586-0…
15
138
13
569
37,361
Register today (by snapping the QR code below) and join us virtually a week from today for the @WCMEnglanderIPM #AI Clinic, "Hardening Your Vibe Analyses with #Mycelium," led by Dr. Arjun Raj (@arjunrajlab) from @UofPenn #BioEngineering #Genetics!
Mark your calendar and plan to join us (virtually) on Nov. 18th at 2 pm for the @WCMEnglanderIPM #AI Clinic "Hardening Your Vibe Analyses with #Mycelium," led by Dr. Arjun Raj (@arjunrajlab) from @UofPenn #BioEngineering #Genetics! Snap the QR code below to register.
1
2
235
🤖 AI and peer review: where does it fit? Our co-director Dr. Aristotelis Tsirigos (@artsinyc) shares his thoughts on the role of AI in peer review in a recent Nature Biotechnology piece: nature.com/articles/s41587-0…
4
6
515
Olivier Elemento retweeted
I had early access to Fable 5.2 for a bit & I think it crosses the line into being a sort of Jagged AGI. Here, I have it launch a business, do academic research, hack hardware, build 3D models & more. I think it is a good illustration of limits & powers: oneusefulthing.org/p/fable-5…
258
339
123
4,275
728,250
Olivier Elemento retweeted
1/n Excited to share AI ECHO INSIGHT, the first blinded, randomized trial of AI for the full echo report, presented today by Keane Lee at #ScientificSessions26 Late-Breaking Science. EchoPrime and EchoNet-Measurements drafted the interpretations and measurements for cardiologist review. #echofirst
17
72
8
265
20,303
Great to recently host Dr. James Mansfield (@JimMansfieldYWG) from @Standard_BioT for the @WCMEnglanderIPM talk "Quantitative Spatial Biology for Complex Cell and Tissue Types." From left @Hiranmayi_Ravi, Dr. Alicia Alonzo, @asbonerw, Drs. Mansfield, V. Motta, and Nick Radio.
1
6
9
417